Literature DB >> 9108615

Liver cirrhosis: epidemiological aspects in Italy.

C De Bac1, C Clementi, F Duca, D Livoli, G Poliandri, A Bozza, A Osso, S Martuscelli, C Pasquazzi, P Petrucci, C Furlan, G Taliani.   

Abstract

In order to improve our knowledge of the incidence of liver cirrhosis in Italy, we conducted two epidemiological studies. The first study showed that about 15% of asymptomatic subjects with persistent increase in alanine aminotransferase had histological evidence of cirrhosis. In this setting, cirrhosis was associated with viral aetiology in 91.4% of cases. In the second study, which enrolled cirrhosis patients from 13 centres from all regions of the country, viral infections were detected in 82.6% of patients, the large majority of whom, 71.2%, were positive for hepatitis C virus (HCV). Alcohol abuse was present in 8.7% of cases as exclusive aetiological factor. All the patients were classified according to Child-Pugh and were scored as class A in 62.4%, as class B in 23.8% and as class C in 13.8% of cases. The age distribution showed that about 55% of cirrhosis patients were under 60 years of age; 34.3% of them had a Child-Pugh score of class B or C. These data show that HCV infection represents the predominant aetiological factor of cirrhosis in Italy and that cirrhosis can be found frequently in asymptomatic subjects.

Entities:  

Mesh:

Year:  1997        PMID: 9108615     DOI: 10.1016/s0923-2516(97)89899-8

Source DB:  PubMed          Journal:  Res Virol        ISSN: 0923-2516


  2 in total

1.  Prediction of oesophageal varices with platelet count/spleen diameter ratio or platelets alone.

Authors:  D Thabut; V Ratziu; J-B Trabut; T Poynard
Journal:  Gut       Date:  2004-06       Impact factor: 23.059

2.  Platelet count/spleen diameter ratio: proposal and validation of a non-invasive parameter to predict the presence of oesophageal varices in patients with liver cirrhosis.

Authors:  E Giannini; F Botta; P Borro; D Risso; P Romagnoli; A Fasoli; M R Mele; E Testa; C Mansi; V Savarino; R Testa
Journal:  Gut       Date:  2003-08       Impact factor: 23.059

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.